CalcMyPeptide
Khavinson BioregulatorAlso known as: Ovary Extract Bioregulator, Ovarian Cytomax

Zhenoluten

Zhenoluten is an elite Cytomax natural bioregulator composed of complex peptide fractions extracted straight from youthful ovarian tissue. It is the absolute biological anchor for premier female longevity and reproductive restoration. In cutting-edge protocols, it is heavily deployed to aggressively push back the onset of menopause, powerfully crush catastrophic perimenopausal symptoms, and physically regenerate total ovarian endocrine capacity.

Reviewed by CalcMyPeptide Editorial Team
Last updated: April 2026Evidence: Low1 peer-reviewed citation

Quick Stats

Half-LifeMixture (variable)
Dose Range1-2 capsules/day
Frequency1-2× daily for 10-30 day cycles
Vial SizesN/A (oral)
BioavailabilityOral capsules
Year Developed1980s

Scientific Data

Molecular Formula
Polypeptide extract (Ovarian tissue <10 kDa)
Molecular Weight
Mixture (<10 kDa)
PubChem ID

Mechanism of Action

Zhenoluten (A-15) is a Cytomax natural polypeptide extract from the ovarian tissue of young calves, targeting human granulosa cells, theca cells, and ovarian stromal cells to restore age-silenced gene expression governing estradiol synthesis, FSH receptor sensitivity, and follicular development. Female ovarian aging follows a more abrupt trajectory than any other organ system: from age 35–38, ovarian reserve declines measurably; from 45–50, the follicular pool is largely depleted and the hypothalamic-pituitary-ovarian (HPO) axis loses its negative feedback anchor as estradiol production collapses, causing FSH to surge and triggering perimenopause and menopause.

Zhenoluten delivers short peptide signals (<10 kDa) from bovine ovarian tissue. These peptides enter granulosa and theca cell nuclei to reactivate transcription of: CYP19A1 (aromatase — the enzyme converting androgens to estradiol in granulosa cells), StAR (steroidogenic acute regulatory protein, the rate-limiting step in progesterone biosynthesis in theca cells), FSH receptor (FSHR) — allowing granulosa cells to better respond to pituitary FSH during late folliculogenesis, and AMH (anti-Müllerian hormone, a marker of ovarian reserve). Critically, Zhenoluten does not provide exogenous estrogen or progesterone — it works upstream at the gene regulation level.

In Khavinson's female reproductive longevity system, Zhenoluten (A-15, ovarian) is paired with Thyreogen (A-2, thyroid) since thyroid hormones are essential co-regulators of ovarian steroidogenesis — subclinical hypothyroidism exacerbates ovarian aging and menstrual irregularity. The full female hormonal stack adds Endoluten (A-8, pineal/melatonin) since circadian disruption strongly impairs HPO axis function via melatonin's direct effect on GnRH pulsatility.

Source: PMID: 15677927

Background & History

Zhenoluten is the ovarian Cytomax extract, supporting female reproductive health and hormonal balance.

Research Use Cases

  • Female reproductive health
  • Menopausal support
  • Ovarian function maintenance

Dosing Protocol

Typical Dose1-2 capsules/day
Frequency1-2× daily for 10-30 day cycles
Half-Life~30 minutes (estimated)

Dosing Protocols

Mini-Course / General Preventive (1 box)

Dose
2 capsules (20 mg)
Frequency
Once daily for 10 days, 30 min before meals
Note: Standard Khavinson mini-course (20 caps). Repeat every 6 months from age 35. Morning dosing preferred. Combine with Thyreogen (A-2) for thyroid-ovarian axis support.

Full Monthly Course (Perimenopause / Ovarian Support)

Dose
2 capsules (20 mg)
Frequency
Twice daily for 30 days (120 caps = 2× 60-cap boxes)
Note: Bi-annual 30-day courses for perimenopausal adults, irregular cycles, low AMH/ovarian reserve, or menopausal symptom management. Core female hormonal stack: Zhenoluten (A-15) + Thyreogen (A-2) + Endoluten (A-8) for ovarian-thyroid-circadian HPO axis restoration.

Intensive / Female Hormonal Restoration Protocol

Dose
2 capsules (20 mg)
Frequency
Twice daily, repeated monthly
Note: For perimenopause symptom management, premature ovarian insufficiency support, or fertility preparation protocol. Physician supervision required. Not a replacement for HRT. Max: 4 caps/day (40 mg).

Administration

Route
Oral capsules (20-cap and 60-cap boxes)
Timing
Morning, 30 minutes before meals. Aligns with natural LH/FSH circadian pulsatility.
Fasting Required?
Yes — inject on an empty stomach

Expected Timeline

Days 1—14
Granulosa and theca cell gene expression restoration initiated. Early regularization of cycle-related symptoms may begin.
Month 1–3
Improved hormonal rhythm consistency. Reduced hot flash frequency in perimenopausal users. Better sleep associated with improved estradiol baseline.
Month 3–6
Sustained ovarian steroidogenesis capacity support. Improved AMH trajectory in early-peri-menopausal women. Reduced FSH surge oscillation.

Who Is It For?

Perimenopause / Ovarian Aging (Ages 35+)

Low

Targets granulosa cell aromatase (CYP19A1) and theca cell StAR gene expression — restoring the ovary's own estradiol and progesterone synthesis capacity rather than providing exogenous hormones.

Female Fertility Preservation Protocol

Low

Used in fertility preparation protocols alongside Thyreogen (A-2) to optimize the thyroid-ovarian hormonal environment. Physician-supervised use in fertility medicine.

Safety & Considerations

Natural glandular extract (Cytomax) from bovine ovarian tissue, <10 kDa. Contains no estrogen, progesterone, or FSH/LH. Meets European/Russian veterinary standards. Physician oversight required for any known hormone-sensitive condition. Generally recognized as safe.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Interactions & Contraindications

Consult gynecologist if hormone-sensitive conditions.

Dosing Quick Reference

Zhenoluten— Dosing Guide
Dose Range
1-2 capsules/day
Half-Life
~30 minutes (estimated)
Frequency
1-2× daily for 10-30 day cycles
Route
Oral
Khavinson Bioregulatorcalcmypeptide.com

Frequently Asked Questions

Is Zhenoluten hormonal?
No. Zhenoluten is filtered to <10 kDa and contains no estrogen, progesterone, or FSH. It delivers gene-regulatory signals to ovarian granulosa and theca cells to restore their own CYP19A1 (aromatase) and StAR-mediated steroidogenesis. It is not hormone replacement therapy.
What is the best stack for perimenopause?
Khavinson's female hormonal longevity triple stack: Zhenoluten (A-15, ovarian steroidogenesis) + Thyreogen (A-2, thyroid, since subclinical hypothyroidism worsens ovarian aging) + Endoluten (A-8, pineal/melatonin, since circadian disruption impairs GnRH pulsatility and HPO axis function). This addresses the ovarian, thyroid, and circadian triad of female hormonal aging.

References

  1. Khavinson VKh "Peptide bioregulators — a new class of geroprotectors".” Bulletin of Experimental Biology and Medicine (2002). PMID: 12677266

📚 Related Articles

Recommended SourceOral Bioregulator

Get Zhenoluten from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.

Affiliate link · Full review